HK Stock MarketDetailed Quotes

VISEN PHARMA-B (02561)

Watchlist
  • 24.700
  • -0.120-0.48%
Noon Break May 21 11:52 CST
2.81BMarket Cap-10.03P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

VISEN PHARMA-B (02561) Revenue Breakdown Overview

By Business/Source

Currency:CNY
2025/FY
Stock NameRevenueRatio
开发并商业化颠覆式内分泌疗法165K100.00%

By Product

Currency:CNY
2025/FY
Stock NameRevenueRatio
开发并商业化颠覆式内分泌疗法165K100.00%

By Country/Region

No Data

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 +5.82%
Sample Name
Sample Code
 +1.34%
Sample Name
Sample Code
 +0.44%
4
SHANGHAI PECHEM
00338
-2.44%
5
CHINA OILFIELD
02883
-3.01%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +40.79%
Sample Name
Sample Code
 +33.19%
Sample Name
Sample Code
 +22.77%
4
Business-intelligence Of Oriental Nations Corporation
300166
+18.10%
5
Thunder Software Technology
300496
+14.54%
View More
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"

- No more -